文献速递细菌感染、耐药与抗菌药物

荷兰革兰阴性菌感染抗生素耐药归因死亡率:平行匹配队列研究

Attributable mortality of antibiotic resistance in gram-negative infections in the Netherlands: a parallel matched cohort study.
PubMed 文献 · Clin Microbiol Infect · 2020-07-19

该研究在荷兰8家医院2013–2016年识别1954例革兰阴性菌感染,按耐药与否分队列,并1:1匹配非感染对照,比较30天死亡率。调整后耐药与敏感感染相对非感染对照的RR分别为1.42(95%CI 0.66–3.09)和1.32(1.06–1.65),两者相除得耐药归因RR为1.08(0.48–2.41),提示荷兰革兰阴性菌感染中抗生素耐药未增加30天死亡率。

要点

  • 耐药革兰阴性菌感染243例(12%),其中3GC-R肠杆菌目189例(78%)。
  • 耐药与敏感感染相对非感染对照的死亡RR分别为1.42和1.32。
  • 耐药归因死亡RR为1.08(95%CI 0.48–2.41),未见死亡率增加。

核心结论

  • 在荷兰,革兰阴性菌感染中抗生素耐药未增加30天死亡率。

研究设计与样本

  • 在8家医院2013–2016年识别革兰阴性菌感染样本,分为耐药与敏感感染队列。
  • 两队列分别按医院、感染发生时住院时长和年龄1:1匹配非感染对照,采用平行匹配队列设计。
  • 共识别1954例革兰阴性菌感染,匹配1941例非感染对照。

主要发现

  • 1954例感染中大肠埃希菌1190例(61%)、铜绿假单胞菌210例(11%)、菌血症758例(39%)。
  • 耐药革兰阴性菌引起243例感染(12%),其中3GC-R肠杆菌目189例(78%)、多重耐药铜绿假单胞菌9例(4%)、产碳青霉烯酶肠杆菌目0例。
  • 调整后耐药感染相对非感染对照的30天死亡RR为1.42(95%CI 0.66–3.09),敏感感染为1.32(95%CI 1.06–1.65)。
  • 两RR相除得耐药归因死亡RR为1.08(95%CI 0.48–2.41)。

临床怎么用

  • 荷兰数据提示耐药革兰阴性菌感染的30天死亡风险与敏感感染相近,可结合本地流行病学解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Antibiotic resistance in Gram-negative bacteria has been associated with increased mortality. This was demonstrated mostly for third-generation cephalosporin-resistant (3GC-R) Enterobacterales bacteraemia in international studies. Yet, the burden of resistance specifically in the Netherlands and created by all types of Gram-negative infection has not been quantified. We therefore investigated the attributable mortality of antibiotic resistance in Gram-negative infections in the Netherlands. METHODS: In eight hospitals, a sample of Gram-negative infections was identified between 2013 and 2016, and separated into resistant and susceptible infection cohorts. Both cohorts were matched 1:1 to non-infected control patients on hospital, length of stay at infection onset, and age. In this parallel matched cohort set-up, 30-day mortality was compared between infected and non-infected patients. The impact of resistance was then assessed by dividing the two separate risk ratios (RRs) for mortality attributable to Gram-negative infection. RESULTS: We identified 1954 Gram-negative infections, of which 1190 (61%) involved Escherichia coli, 210 (11%) Pseudomonas aeruginosa, and 758 (39%) bacteraemia. Resistant Gram-negatives caused 243 infections (12%; 189 (78%) 3GC-R Enterobacterales, nine (4%) multidrug-resistant P. aeruginosa, no carbapenemase-producing Enterobacterales). Subsequently, we matched 1941 non-infected controls. After adjustment, point estimates for RRs comparing mortality between infections and controls were similarly higher than 1 in case of resistant infections and susceptible infections (1.42 (95% confidence interval 0.66-3.09) and 1.32 (1.06-1.65), respectively). By dividing these, the RR reflecting attributable mortality of resistance was calculated as 1.08 (0.48-2.41). CONCLUSIONS: In the Netherlands, antibiotic resistance did not increase 30-day mortality in Gram-negative infections.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Rottier WC, Deelen JWT, Caruana G, et al. Attributable mortality of antibiotic resistance in gram-negative infections in the Netherlands: a parallel matched cohort study. Clin Microbiol Infect. 2020. PMID: 32698043. doi:10.1016/j.cmi.2020.07.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。